Similar phenomena can be also detected in prostate cancer cells, where RGS2 inhibits cell growth with the decreased RGS2 expression while RGS17 enhances cell growth with the increased RGS17 expression [72, 137, 138]. The gene discussed is RGS17; the disease is prostate carcinoma.